These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25673035)

  • 1. Antibiotics and extracorporeal circulation--one size does not fit all.
    Gonçalves-Pereira J; Oliveira B
    Crit Care; 2014 Dec; 18(6):695. PubMed ID: 25673035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge.
    Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD
    Crit Care; 2015 Jun; 19(1):263. PubMed ID: 26095659
    [No Abstract]   [Full Text] [Related]  

  • 3. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.
    Shekar K; Fraser JF; Smith MT; Roberts JA
    J Crit Care; 2012 Dec; 27(6):741.e9-18. PubMed ID: 22520488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
    Jamal JA; Economou CJ; Lipman J; Roberts JA
    Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring for meropenem after the extracorporeal membrane oxygenation circuit change in children: is it necessary?
    Di Nardo M; Cairoli S; Goffredo BM; Stoppa F; D'Argenio P; Corsetti T; Ranieri VM
    Minerva Anestesiol; 2016 Sep; 82(9):1018-9. PubMed ID: 27096330
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?
    Shekar K; Roberts JA; Ghassabian S; Mullany DV; Wallis SC; Smith MT; Fraser JF
    J Antimicrob Chemother; 2013 Mar; 68(3):726-7. PubMed ID: 23111850
    [No Abstract]   [Full Text] [Related]  

  • 8. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
    Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter?
    Abdul-Aziz MH; Roberts JA
    Curr Opin Anaesthesiol; 2020 Feb; 33(1):71-82. PubMed ID: 31764007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics in critically ill patients.
    Varghese JM; Roberts JA; Lipman J
    Curr Opin Anaesthesiol; 2010 Aug; 23(4):472-8. PubMed ID: 20489605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic dose optimization in critically ill patients.
    Cotta MO; Roberts JA; Lipman J
    Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic Dosing in Continuous Renal Replacement Therapy.
    Shaw AR; Mueller BA
    Adv Chronic Kidney Dis; 2017 Jul; 24(4):219-227. PubMed ID: 28778361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.
    Wi J; Noh H; Min KL; Yang S; Jin BH; Hahn J; Bae SK; Kim J; Park MS; Choi D; Chang MJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill.
    Tsai D; Lipman J; Roberts JA
    Curr Opin Crit Care; 2015 Oct; 21(5):412-20. PubMed ID: 26348420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Meropenem Pharmacokinetics in an Experimental Acute Respiratory Distress Syndrome (ARDS) Model during Extracorporeal Membrane Oxygenation (ECMO) by Using a PenP
    Andresen M; Araos J; Wong KY; Leung YC; So LY; Wong WT; Cabrera S; Silva C; Alegria L; Bruhn A; Soto D
    Sensors (Basel); 2018 May; 18(5):. PubMed ID: 29734646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
    Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
    BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
    Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
    ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.